A New Tetrapeptide Biomimetic Chromatographic Resin for Antibody Separation with High Adsorption Capacity and Selectivity
Yu-Ming Fang,Sheng-Gang Chen,Dong-Qiang Lin,Shan-Jing Yao
DOI: https://doi.org/10.1016/j.chroma.2019.460474
2019-01-01
Abstract:Biomimetic affinity chromatography with short peptide ligands is a developing technology, which has great potential for antibody separation and purification. In this study, a tetrapeptide library with critical residues of natural ligands to hIgG was constructed and a novel tetrapeptide ligand (Ac-FYHE) with high LibDock scores was selected by molecular docking. Then, Ac-FYHE ligand was linked to agarose bead to prepare a new chromatography resin. The properties of antibody adsorption were measured and evaluated by static/dynamic adsorption. It was found that the resin with ligand Ac-FYHE has high binding capacity and selectivity for hIgG. The results showed the Q(m-hIgG) of Ac-FYHE-4FF resin was 87.9 mg/g resin while the Q(m-BSA) of this resin was only 16.5 mg/g resin at pH 7.0. Moreover, at pH 7.0, Q(10%) of Ac-FYHE-4FF resin was 24.1 mg/mL for hIgG but just 2.1 mg/mL for BSA, which presented high selectivity of the screened resin at pH 7.0. Subsequently, the adsorption and separation properties of the Ac-FYHE-4FF resin were further investigated. As a result, with the addition of 0.5 M NaCl, Q(m) decreased by less than 20% but Q(m) decreased by 70% with the addition of 50% (v/v) ethylene glycol, which indicated that hydrophobic interaction would be the driving force for the binding between resin and hIgG. Besides, pH 7.5 and pH 4.5 could be the optimal loading and elution condition for hIgG, respectively. Finally, the Ac-FYHE-4FF resin was applied to separate mAb or/and hIgG from BSA containing feedstock, CHO cell culture supernatant and human serum, and the purity and recovery were both more than 90% with only one-step separation. The results indicate that the Ac-FYHE-4FF resin developed in this work would be promising for antibody separation and purification. (C) 2019 Elsevier B.V. All rights reserved.